On February 17, 2026, Pulse Biological Sciences (PLSE) disclosed six insider trading transactions. Executive Danahy Kevin Patrick sold 20,000 shares on February 17, 2026.
[Recent Insider Transactions]
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share/USD
Total Amount/USD
February 17, 2026
Executive
Danahy Kevin Patrick
February 17, 2026
Buy
60,000
1.53
91,800
February 17, 2026
Executive
Danahy Kevin Patrick
February 12, 2026
Sell
20,000
23.37
467,400
February 17, 2026
Executive
Danahy Kevin Patrick
February 17, 2026
Sell
20,000
23.63
472,600
February 17, 2026
Executive
Danahy Kevin Patrick
February 13, 2026
Sell
20,000
23.53
470,600
February 11, 2026
Executive
Danahy Kevin Patrick
February 10, 2026
Sell
20,000
23.52
470,400
February 11, 2026
Executive
Danahy Kevin Patrick
February 9, 2026
Sell
20,000
21.45
429,000
February 11, 2026
Executive
Danahy Kevin Patrick
February 11, 2026
Buy
60,000
1.53
91,800
February 11, 2026
Executive
Danahy Kevin Patrick
February 11, 2026
Sell
20,000
25.20
504,000
October 7, 2025
Executive
Danahy Kevin Patrick
October 2, 2025
Buy
4,600
1.53
7,038
October 7, 2025
Executive
Danahy Kevin Patrick
October 2, 2025
Sell
4,600
18.53
85,200
[Company Information]
Pulse Biological Sciences, Inc. was incorporated in Nevada on May 19, 2014, under the name Electroblate, Inc. It is a medical device company developing a new and proprietary platform technology, nanosecond pulsed electrical signals, or NPES, for biomedical applications. Electroblate, Inc. changed its name to Pulse Biological Sciences, effective December 8, 2015.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | Pulse Biosciences Discloses 6 Insider Transactions on February 17
On February 17, 2026, Pulse Biological Sciences (PLSE) disclosed six insider trading transactions. Executive Danahy Kevin Patrick sold 20,000 shares on February 17, 2026.
[Recent Insider Transactions]
[Company Information]
Pulse Biological Sciences, Inc. was incorporated in Nevada on May 19, 2014, under the name Electroblate, Inc. It is a medical device company developing a new and proprietary platform technology, nanosecond pulsed electrical signals, or NPES, for biomedical applications. Electroblate, Inc. changed its name to Pulse Biological Sciences, effective December 8, 2015.